Found 135 matching trials
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
PHASE1The purpose of this study is to determine if the use of exploratory immunol...
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Stereotactic Ablative Radiation Therapy for Prostate Cancer
NAThis single arm trial will investigate a novel way to plan and deliver SABR...
Status
Active Not Recruiting
Location
Medical University of South Carolina Hollings Cancer Center
Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer
PHASE1The goal of this clinical trial is to assess safety of pan-metastases direc...
Location
Centre Léon Bérard
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
PHASE1This study aims to determine the safety and tolerability of combined Atezol...
Location
Chilldren's Healthcare of Atlanta
Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer
PHASE2Pancreatic cancer, most commonly adenocarcinoma, is the fourth leading caus...
Status
Active Not Recruiting
Location
University of Nebraska Medical Center
Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC
PHASE2Background: Stereotactic body radiotherapy (SBRT) is a standard definitive ...
Location
Prince of Wales Hospital
Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma
PHASE2Patients with advanced pancreas adenocarcinoma will be randomized on a 6:1 ...
Status
Active Not Recruiting
Location
Washington University School of Medicine
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
PHASE2For this study, unfavorable intermediate risk prostate cancer patients will...
Location
NYU Langone Health
SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N
NATo derive the maximum tolerated dose of hypofractionated stereotactic body ...
Location
Radiotherapy department, University Hospital Ghent
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
PHASE1The study is an open-label phase I/II clinical trial. The study will enroll...
Location
Washington University School of Medicine